Amendments for: 172-2019-2020-Q2-931269

Current (Dec 13, 2019)
Agreement Value: $205,475.00
Agreement: Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement (931269). Jul 8, 2019 - Mar 18, 2020
Description:

Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: DGI Clinical Inc. (For-profit organization)
Location: Halifax, Nova Scotia, CA B3J 2E3
Type: Contribution
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.

Federal Riding Name: Halifax (12005)
Program Name: Industrial Research Assistance Program – Contributions to Firms

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 541710
Amendment 01 (Dec 13, 2019)
Agreement Value: $205,475.00
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.

Amendment 00
Agreement Value: $149,000.00
Agreement: Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement (931269). Jul 8, 2019 - Dec 31, 2019
Description:

Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: DGI Clinical Inc. (For-profit organization)
Location: Halifax, Nova Scotia, CA B3J 2E3
Type: Contribution
Federal Riding Name: Halifax (12005)
Program Name: Industrial Research Assistance Program – Contributions to Firms

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 541710